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Highlights 
 The immunophilin FKBP52 is known to modulate hallmarks of Alzheimer’s disease 
 Downregulation of FKBP52 levels does not alter cognitive performance with ageing 
 Reduced FKBP52 levels lead to impaired motor coordination 
 
Abstract 
FKBP52 is a ubiquitously distributed immunophilin that has been associated with wide-
ranging functions in cell signalling as well as hormonal and stress responses. Amongst other 
pathways, it acts via complex-formation with corticosteroid receptors and has consequently 
been associated with stress- and age- related neurodegenerative disorders including 
Alzheimer’s and Parkinson’s diseases. Reduced levels of FKBP52 have been linked to tau 
dysfunction and amyloid beta toxicity in AD. However, FKBP52’s role in cognition and 
neurodegenerative disorder-like phenotypes remained to be elucidated. 
The present study aimed therefore at investigating the cognitive and behavioural effects of 
reduced FKBP52 levels of genetically modified mice during ageing. Female and male 
FKBP52+/+, FKBP52+/- and FKBP52-/- mice were compared at two-, ten-, twelve-, fifteen- 
and eighteen-months-of-age in a series of behavioural tests covering specie-specific 
behaviour, motor activity and coordination, fear-, spatial and recognition memory as well as 
curiosity and emotionality. 
Whilst cognitively unimpaired, FKBP52+/- mice performed worse on an accelerating rotating 
rod than FKBP52+/+ littermates across all age-groups suggesting that FKBP52 is involved in 
processes controlling motor coordination. This deficit did not exacerbate with age but did 
worsen with repeated testing; pointing towards a role for FKBP52 in learning of tasks 
requiring motor coordination abilities. 
This study contributes to the knowledge base of FKBP52’s implication in neurodegenerative 
diseases by demonstrating that FKBP52 by itself does not directly affect cognition and may 
therefore rather play an indirect, modulatory role in the functional pathology of AD, whereas 
it directly affects motor coordination, an early sign of neurodegenerative damages to the 
brain. 
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1 Introduction 
FKBP52 is classed as an FK506-binding immunophilin of high molecular mass (52 kDa) [1] 
expressed in a variety of mammalian tissue cells including nervous cells [2]. With its 
tetratricopeptide repeat domains in its C-terminus part, it acts as a chaperone in protein 
folding; and partakes in the hormonal metabolism by binding to progesterone- and androgen- 
receptors [1, 3]. Its peptidyl-propyl cis/trans isomerase domain is necessary for its interaction 
with glucocorticoid receptors (GRs) [1, 4]. FKBP52 participates to the nuclear transport 
of and activation of GRs [5], and as such, is involved in the stress system [6, 7]. FKBP52 
also binds to the mineralocorticoid receptor-heat shock protein 90 (MR-Hsp90) complex 
[8] favouring the cytoplasmic transport of MR to the nucleus [9]. By regulating MR 
function, FKBP52 can thus modulate neuronal function and survival as well as 
behaviours related to stress, mood and learning [10]. 
As a glucocorticoid receptor regulator, FKBP52 is implicated in the hypothalamic-pituitary-
adrenal axis [4] which is crucial for brain ageing; and higher levels of FKBP52 have been 
measured in aged (twenty-six-month-old) C57Bl/6N mice when compared to six-month-old 
C57Bl/6N mice [11]. This age-related FKBP52 increase is not associated with recognition 
memory performance in senescent mice [11]. FKBP52 is expressed in brain areas such as in 
the hippocampus, frontal cortex, amygdala and basal ganglia [12] which are also implicated 
in the pathology of a number of neurodegenerative diseases, such as Alzheimer’s disease 
(AD) and Parkinson’s disease. Traditionally, AD is characterised by accumulation and 
aggregation of two proteins, namely amyloid beta (Aβ) and tau. Small soluble Aβ aggregates 
and neurofibrillary tangles (created by tau aggregation) appear to be good indicators of AD 
severity [13]. FKBP52 has shown to interact with both proteins, whereby it modulates Aβ 
toxicity [12] and prevents microtubule formation by tau [14].  FKBP52 expression has been 
found to be particularly low in the frontal cortex of deceased AD patients [15]. This suggests 
that reduced FKBP52 levels are a risk factor for cognitive decline. 
Whilst FKBP52 has been found to alter Aβ or tau processing in cell cultures [12, 14] but 
it is it is unclear to what extent this affects functional aspects that are traditionally 
associated with Aβ or tau accumulations, e.g. cognitive decline. Furthermore, FKBP52 
levels are altered in the ageing brain [11], and therefore this may affect the severity of 
behavioural decline in ageing and/or behaviours relevant to neurodegenerative diseases 
other than AD. The aim of the present study was, therefore, to determine cognitive and 
behavioural effects of reduced FKBP52 levels in behavioural ageing per se using a 
comprehensive test battery covering species-specific behaviour, motor coordination, 
locomotor activity, spatial and recognition memory as well as fear learning and 
memory, sensory motor gating and emotionality. Given the association of FKBP52 with 
the reproductive system [3] female and male FKBP52+/+ and FKBP52+/- mice were compared.  
 
2 Materials and methods 
2.1 Animals 
FKBP52+/- mice, generated as previously described [16], were obtained from the Indiana 
University School of Medicine (Indianapolis, USA). FKBP52+/+, FKBP52+/- and FKBP52-/- 
mice were bred on a mixed 129SvJ x C57Bl/6J background at the Bio Support Unit of the 
University of Nottingham (Nottingham, UK). Genotyping was carried out by Transnetyx 
(Cordova, USA). Separated by sex, animals were group-housed in individually ventilated 
cages (38 cm x 20 cm x 13 cm). These were supplied with ad libitum food and water, sawdust 
flooring, bedding material, cardboard tubes and wooden chewing sticks for environmental 
enrichment. Temperature, relative humidity and air exchange were kept consistent in holding 
rooms and behavioural testing suites. Lighting in holding rooms was maintained at a 12/12, 
24 hour light/dark cycle, with lights on at 07h00. All procedures were performed according to 
the Animals (Scientific Procedures) Act 1986, under project license 40/3601; and reported 
according to the ARRIVE guidelines [17]. 
 
The number of mice used for all three experiments are listed in table 1. Power analysis based 
on preliminary accelerod data acquired from ten-month-old female and male FKBP52+/- and 
FKBP52+/+ mice suggested the use of twelve mice per genotype and age-group in order to 
detect a genotype-related difference with a 90 % power. Throughout the study, 13 fifteen-
month-old and twelve eighteen-month-old mice were lost due to spontaneous death. In 
experiment 3, six female FKBP52-/- mice were compared to six female FKBP52+/- and 
FKBP52+/+ mice. The five male FKBP52-/- mice, however, displayed inter-sex characteristics 
externally, with underdeveloped testicles upon dissection, and their ambiguous sex 
questioned the use of males as appropriate controls 
 
2.2 Experimental design 
The initial experiment tested ten- and twelve-month-old mice of both sexes towards the end 
of their reproductive period in a longitudinal study (experiment 1). Genotype differences that 
evolved between these two age groups could either be ascribed to advancing age or repeated 
testing. Hence, in experiment 2, experimentally naïve male and female FKBP52+/+ and 
FKBP52+/- mice underwent the same tests at two-, twelve-, fifteen- and eighteen- months-of-
age, covering the beginning and end of the reproductive period, as well as senescence, to 
confirm whether these effects were persistent and exacerbated with advanced age. The ideal 
of observing FKBP52+/+, FKBP52+/- and FKBP52-/- mice over a period of time to study the 
consequences of FKBP52 reduction and loss could not be realised due to breeding issues. It 
appeared that the majority of FKBP52-/- mice died at birth, to the effect that only 12 FKBP52-
/- mice out of a 1300-mouse-strong colony survived birth; confirming previously reported 
breeding problems [18]. The surviving homozygous knock-outs were tested together with 
FKBP52+/- and FKBP52+/+ mice at twelve-months-of-age only (experiment 3) and were used 
to confirm the results that were obtained from experiment 2. Figure 1 depicts the order of 
tests that were applied in order of increasing severity [19]. 
 
2.3 Statistical analysis  
Data are presented as mean ± SEM. All analyses of variance and covariance 
(ANOVA and ANCOVA, respectively), as well as mixed model repeated measures analyses 
in the following were conducted using InVivoStat (v. 2.5; Geiszler, Barron [20]). One-sample 
t-tests were performed using SPSS v. 21.0.0.0 (IBM SPSS Statistics). An effect was 
considered significant when p values were ≤ 0.05 and post-hoc planned comparisons were 
used where appropriate. Only statistically significant effects due to genotype or its 
interactions with other factors (e.g. age or sex) are illustrated in the main manuscript. 
Remaining data is presented in the supplementary material. Data collected in experiment 3 
was graphically represented and described but not statistically compared due to the sexual 
ambiguity of FKBP52-/- male mice. 
2.4 Body mass 
All animals were weighed before they went on experiment on day 0, and again on days 4 and 
14. In experiment 1, day 0 data were analysed by three-way mixed model with repeated 
measures; with genotype and sex as between-subject factors and age as the repeated factor. In 
experiment 2, day 0 data were analysed by single-measures three-way ANOVA, with 
genotype, age and sex as between-subject factors.  
 
2.5 Behavioural and cognitive tests 
2.5.1 Food burrowing  
Food burrowing assesses a species-specific behavioural analogue of daily living activity [21, 
22]. For the duration of this test, mice were singly housed in individually ventilated cages 
that were equipped like their home cages. In addition to their usual diet, mice were presented 
with a glass jar that contained small pellet, high-nutrient food (50 g). The percentage of food 
displaced from each jar between 5 pm and 9 am the following morning was recorded. Food 
displacement data were analysed by a three-way mixed model approach with repeated 
measures in experiment 1; using genotype, age and sex as between-subject factors and body 
mass as covariate. Data from experiment 2 were analysed by a three-way ANCOVA, with 
genotype, age and sex as between-subject factors and body mass as covariate.  
 
2.5.2 Spontaneous alternation  
The spontaneous alternation performance was tested in a Y-shaped maze. In this study the 
maze was made of transparent polyacrylate (44 cm long x 7 cm wide x 25 cm high; three 
identical arms 120° apart). Mice were placed in the centre and allowed to move freely for 5 
minutes. The number of arms entered was counted as a measures of locomotor activity and 
exploratory behaviour [23]. Entries into an arm that differed from the previous two were 
accepted as successful alternation, indexing spatial short-term working memory [24, 25]. The 
alternation rate (%) was calculated as follows: 100 x number of alternations / (number of arm 
entries – 1). The number of arms entered and alternation rate were analysed by either three-
way mixed model repeated measures approach (experiment 1); with genotype and sex as 
between subject-factors and age as the repeated factor; or by three-way single measures 
ANOVA (experiment 2), with genotype, age and sex as between-subject factors. An 
alternation rate significantly above 50 % (random chance) indicates the use of a spatial 
working memory strategy [26] which was tested using a one sample t-test in all three 
experiments. 
2.5.3 Open field and novel object  
Mice were first individually habituated to the empty open-field arena (35 cm x 30 cm x30 cm 
height) for 30 minutes. Ethovision tracking software (v. 7.0; Noldus, Wageningen, 
Netherlands) was used to acquire the distance mice moved as measurement of locomotor 
activity [27]. To evaluate anxiety-like behaviour [27], the relative distance they moved in the 
centre of the arena (21 cm x 6 cm) was calculated [28] to ensure that any differences in object 
exploration levels between treatment groups were due to differences in memory and not 
activity and/or anxiety levels. 
The novel object tasks were used to assess location and recognition memory on day 2. These 
tasks exploit the natural tendency of mice to preferentially explore novel, over familiar 
objects [29] and their locations. The procedure used here was adapted from a previously 
validated protocol [30]. The objects were striped, wooden, prisms with a circular or triangular 
area. All mice were subjected to 3 trials over a period of 36 minutes. In the habituation trial, 
mice were presented with two identical objects placed adjacent to each other for six minutes. 
Ten minutes later, the mice were presented with the same objects – albeit one had moved to 
the opposite corner in the arena – for another six minutes (location trial). Twenty minutes 
after the second trial, the mice were returned to the arena for the discrimination trial where 
one of the two objects was replaced by an object of a different shape (discrimination trial). 
Ethovision tracking software was used to record the duration of exploration of each object in 
each trial, where exploration was defined as detection of the nose-point ≤ 1 cm from each 
object. Mice exhibiting a total exploration time of less than five seconds in any one trial were 
excluded from analysis due to insufficient exploration.  
Open field and novel object data were analysed by either a three-way mixed model repeated 
measures approach (experiment 1); with genotype and sex as between-subject factors and age 
as the repeated factor; or by a three-way single measure ANOVA (experiment 2) with 
genotype, age and sex as between-subject factors. The preference indices were also compared 
to chance levels (50 %) using a one sample t-test. 
2.5.4 Accelerod  
Motor coordination was assessed using a modified rotarod test protocol [31-33]. The 
accelerating rotarod (Harvard apparatus) consisted of a rotating, white, ridged rubber rod, 
separated by fixed, white polyacrylate partitions into five, 6-cm-wide sections. Accelerod 
experiments were carried out in three trials, consisting of two runs each, over three days, in 
which each mouse was placed onto the rod which rotated at a baseline speed of 4 rpm. Over 
the following ten minutes time the rod steadily accelerated up to a maximum of 40 rpm. The 
latency to fall from the accelerating rod indicated motor coordination performance. This was 
noted for each run and subsequently averaged for each trial. If mice reached the maximum 
limit of ten minutes, they were removed from the rod and given the maximum time. The 
effect of age or repeated testing on latency to fall in experiment 1 was assessed by calculation 
of a performance index, where performance index = (trial 9 latency – trial 1 latency)/trial 9 
latency x 100. 
Latency to fall acquired in experiment 1 was analysed within each age group by three-way 
mixed model with repeated measures; with genotype and sex as between-subject factors and 
trial as the repeated factor. The performance index was analysed by three-way mixed model 
repeated measures approach using genotype and sex as in-between factors and age as 
repeated factor. Latency to fall data acquired in experiment 2 were analysed by four-way 
mixed model with repeated measures; using genotype, age and sex as between-subject factors 
and trial as the repeated factor. Body mass was considered as covariate in all analyses. 
2.5.5 Acoustic startle response and prepulse inhibition  
The startle response comprises a contraction of skeletal muscles elicited by a sudden, intense 
stimulus [34]. If this stimulus is preceded by a non-startling stimulus the magnitude of the 
response can be reduced (prepulse inhibition); which is understood to measure sensorimotor 
gating and the ability to process information [34]. The test protocol used here was adapted 
from [35]. Acoustic stimuli were delivered and startle responses measured via a piezoelectric 
sensor in a two-unit automated startle system (SR Lab software; San Diego Instruments, San 
Diego, CA, USA). The startling pulse consisted of a single white noise burst (40 ms at 120 
dB). The prepulse + pulse trials consisted of a prepulse of noise (20 ms at 68, 72, 80 and 90 
dB respectively) followed by startling pulse 100 ms after prepulse onset. The protocol began 
with a five-minute-long acclimation period at background noise level (no-stimulus). The 
following 84 trials consisted of 24 startling pulse trials, 12 no-stimulus trials and 48 prepulse 
+ pulse trials (12 of each prepulse amplitude) in pseudorandom order. Inter-trial intervals 
were pseudo-randomly distributed between 12-30 seconds. The indices measured from raw 
output data were startle latency, startle magnitude and % prepulse inhibition [100*(prepulse + 
pulse amplitude/pulse amplitude alone)] to assess the mice’s responsiveness to stressful 
situations [36]. 
Startle latency and startle magnitude were analysed by either a three-way mixed model 
approach with repeated measures; with genotype and sex as between-subject factors and age 
as the repeated factor (experiment 1) or by three-way single measure ANCOVA, with 
genotype, age and sex as between-subject factors (experiment 2). Body mass was entered as 
covariate in all cases. % prepulse inhibition data of experiment 1 were analysed within each 
age group by three-way mixed model approach with repeated measures; with genotype and 
sex as between-subject factors and dB level of the prepulse as repeated factor, whereas data 
of experiment 2 were analysed by four-way mixed model repeated measures approach; with 
genotype, age and sex as between-subject factors and prepulse dB level as repeated. Body 
mass was used as covariate. 
2.5.6 Contextual fear conditioning  
The protocol used here has been described previously [28] and was used to assess acquisition, 
retention and extinction of contextual memory [37].  
On each day of this three-day-long experiment, mice were placed individually in a test 
chamber (25 cm x 22 cm) consisting of a metal grid floor, three metal walls and one clear 
polyacrylic wall. The Ethovision tracking software recorded the time mice spent immobile, 
which was defined as less than 0.75% change of mouse “area” as viewed from above. For the 
acquisition trial, mice were placed into the test chamber and administered electric foot shocks 
every minute (0.4 mA, one-second-long, every minute) for ten minutes. An increase in the 
time the mice spent immobile with incrementing number of shocks indicated positive 
learning of the averseness of the context (the chamber). 
In experiment 1, the effect of genotype and sex on associative learning was assessed per age-
group. The statistical analysis included three-way mixed model approach with repeated 
measures; with genotype and sex as between-subject factors and number of shocks as the 
repeated factor. In experiment 2, a four-way mixed model repeated measures strategy 
analysed immobility data; with genotype, age and sex as between-subject factors and number 
of shocks as repeated factor.  
Retention and extinction trials were carried out after a 24- and 48-hour-long delay, 
respectively, whereby mice were presented with the same test chamber for three-minutes 
without receiving foot shocks. The length of time the mice spent immobile in the second trial 
was used as a measure of retention of contextual fear memory. The extinction index (time 
immobile during extinction trial minus immobility time during retention trial) indicated 
extinction of contextual fear memory. A negative value suggested successful extinction.  
Immobility data of the retention and extinction trials as well as the extinction indices were 
analysed by a three-way repeated measures mixed model strategy; with genotype and sex as 
between-subject factors and age as repeated factor in experiment 1; whilst data obtained from 
experiment 2 were analysed by three-way single measure ANOVA (genotype, age and sex as 
between-subject factors). The difference of extinction index values from 0 was assessed by 
student’s t-test in all experiments.  
2.5.7 Elevated plus maze  
The elevated plus maze test was used to assess anxiety-like behaviour in mice by exploiting 
their natural aversion for open, elevated spaces and their conflicting desire to explore novel 
surroundings [38]. This test was performed according to a previously described procedure 
[7]. The plus-maze was made of white polyacrylate, consisting of four arms (5 cm x 35 cm 
each); two ‘closed’ arms with white walls (12 cm high) and two ‘open’ arms without any 
walls; held at a one-meter-high elevation. Each mouse was left to explore the maze for five 
minutes which was tracked by Ethovision. The percentage of the time the mice spent in the 
open arms over closed arms was calculated and used as a measure of anxiety-like behaviour. 
Mice that fell from the maze during their trial were excluded from the analysis. 
The percentage of time that the mice spent in the open arm was analysed by a three-way 
repeated measures mixed model strategy with genotype and sex as between-subject factors 
and age as repeated factor in experiment 1. Data obtained from experiment 2 were analysed 
by three-way single measure ANOVA, where genotype, age and sex were used as between-
subject factors.  
 
3 Results 
The focus of the study was the impact of FKBP52 downregulation with ageing. All 
AN(C)OVA and mixed model repeated measures analysis results are listed in the 
supplementary material (Supplementary Tables 1 and 2). Table 2 summarizes the significant 
effects of genotype in the test battery, which are described in detail below. Age- and sex-
related effects, independent of genotype, are detailed in the supplementary material. 
 
3.1 Body mass 
In the first experiment, the mice’s body mass increased between ten- and twelve-months-of-
age irrespective of sex (age: F(1, 43) = 101.67, p < 0.0001; Figure 2A). The effect of genotype 
on the mice’s body mass (F(1, 43) = 5.28, p = 0.0265) was solely due to females. Female 
FKBP52+/- mice were heavier than their FKBP52+/+ littermates (p = 0.0084 and p = 0.0043 at 
ten and twelve-months-of-age, respectively), although the genotype x sex interaction failed to 
reach the critical level of significance (F(1, 43) = 3.3, p = 0.0761).  
The age-dependent increase in body mass was confirmed when considering a wider age 
range, from two- to eighteen-months-of-age (experiment 2; age: F(3, 151) = 136.05, p < 
0.0001); with twelve-, fifteen- and eighteen-month-old mice being heavier than two-month-
old mice (p < 0.001 in all cases); and eighteen-month-old male mice also being heavier than 
twelve- and fifteen-month-old male mice (p = 0.0001 and p < 0.0001, respectively; Figure 
2B). The genotype-related difference in body mass seen in experiment 1, was, however, no 
longer apparent across the wider age range in experiment 2 or at twelve-months-of-age in 
experiment 3 (Figure 2C).  
Overall, downregulation of FKBP52 levels did not affect body mass regardless of age. 
 
3.2 Food burrowing 
Food burrowing performance was not affected by genotype in any of the three experiments 
(Supplementary Figures S1 A, B and C); but showed a trend towards a decline from two- to 
eighteen-months-of-age (experiment 2: F(3, 150) = 2.53, p = 0.0594; S1 B). The decrease of 
food displaced with advancing age is consistent with previous observations (e.g. [20]), but 
performance may be affected by the age-related increase in body mass; as this variable was 
found to be significant covariate in the statistical analysis (p = 0.0238).   
3.3 Spontaneous alternation 
In experiment 1, ten- and twelve-month-old FKBP52+/- mice visited as many arms of the Y-
maze as age-matched FKBP52+/+ mice (Figure 3A). By contrast, statistical analysis of two-, 
twelve-, fifteen- and eighteen-month-old naïve FKBP52+/+ and FKBP52+/- mice of 
experiment 2 indicated that the number of arms entered was dependent on their genotype and 
age (F(3, 151) = 2.99, p = 0.033). This was only significant at the fifteen-months-of-age level 
where female FKBP52+/- mice visited more arms than their FKBP52+/+ littermates (p = 
0.0062; Figure 3B).  
Results of experiment 1 suggested that the number of arms visited was affected by mouse age 
and sex irrespective of genotype (age x sex: F(1, 43) = 13.92, p = 0.0006, Figure 3A). This 
result was due to ten-month-old male mice visiting less arms than their female counterparts (p 
= 0.0288) and twelve-month-old male mice (p = 0.0005); the latter of which visited more 
than age-matched females (p = 0.0153). In experiment 2, the number of arms entered 
decreased with age (F(3, 151) = 15.7, p < 0.0001) and was affected by sex (F(1,151) = 4.96, p = 
0.0275) but not by their interaction. At age-level, sex differences were only noted in 
FKBP52+/+ mice at fifteen-months-of-age (p = 0.0292; Figure 3B).  
In summary, downregulation of FKBP52 expression had no consistent effect on the mice’s 
willingness to explore the Y maze or their spatial working memory. In experiments 1, 2 and 
3, all mice alternated arm entries equally and in most cases above chance levels 
(Supplementary Figures S2 A, B and C, respectively). 
 
3.4 Open field  
FKBP52+/- and FKBP52+/+ mice displayed a similar levels of ambulation in the open field in 
experiment 1, 2, and 3. The distance travelled in the arena declined from two- to eighteen-
months-of-age (experiment 2; F(3, 151) = 13.78, p < 0.0001; Figure 4).  Twelve-month-old 
female FKBP52-/- mice of experiment 3, however, covered a greater distance than their 
female FKBP52+/+ and FKBP52+/- littermates which was comparable to the performance of 
male FKBP52+/+ and FKBP52+/- mice. Conversely, twelve-month-old male FKBP52-/- mice 
(presenting characteristics of prostate dysgenesis) appeared to be less active than male 
FKBP52+/+ and FKBP52+/- mice but the opposite was observed in female. In summary, partial 
knock-down of FKBP52 did not appear to affect locomotor activity. Anxiety-related 
behaviour, assessed through the relative distance covered in the centre of the open field, was 
not affected by the mice’s genotype (Supplementary Figures S3 A, B and C). 
 
3.5 Novel object location and recognition  
The total time the mice spent exploring both objects was not influenced by the mice’s 
genotype in any of the three experiments, regardless of the trial (Supplementary Figures S4 A 
- I). During the habituation trial, mice equally explored both objects, regardless of their 
location, in all three experiments (Supplementary Tables T1 and T2). There was no effect of 
the genotype on discrimination of the novel location (Supplementary Figures S5 A, B and C).  
With regards of object recognition, in experiment 1, where mice were repeatedly tested at 
ten- and twelve-months-of-age, heterozygosity for FKBP52 affected the preference for the 
novel over familiar object (F(1,43) = 4.34, p = 0.0435); whereby twelve-month-old female 
FKBP52+/- mice explored the novel object less than their FKBP52+/+ littermates (p = 0.0435; 
Figure 5A). This difference was not significant in females at ten-months-of-age or in male 
mice. Experimentally naïve mice of experiment 2 or 3 (Figures 5 B and C) were generally 
unable to discriminate the novel over familiar object, regardless of their age. 
In summary, the data collected here does not support a role for FKBP52 in object exploration 
or discrimination and spatial discrimination.  
 
3.6 Accelerod 
The time the mice spent on the accelerating rod increased with rising number of trials the 
mice were subjected to; suggesting that all groups improved their motor coordination with 
training in experiment 1 at ten- (F(8, 272) = 38.6, p < 0.0010; Figures 6A and E) and twelve-
months-of-age (F(8, 272) = 14.56, p < 0.0010; Figures 6B and F) as well as in experiment 2 (F(8, 
1200) = 69.68, p < 0.0010 Figures 7A - H) and experiment 3 (visual inspection Figures 6D and 
H). In all experiments this improvement was affected by the mice’s genotype in an age-
dependent manner: experiment 1 (performance index: genotype x age: F(1, 33) = 4.25, p = 
0.0472) and experiment 2 (genotype x age x trial: F(24, 1200) = 2.26, p = 0.0005); and was also 
influenced by the mice’s sex in experiment 1 (genotype x sex x trial: F(8, 272) = 2.02, p = 
0.0441) and 2 (age x sex x trial: F(24, 1200) = 1.82, p = 0.0089).  
The genotype-related differences became apparent in ten- and twelve-month-old female mice 
of experiment 1, whereby FKBP52+/- mice fell from the accelerating rod before FKBP52+/+ 
mice in the final trial (p = 0.0333, and p = 0.0394, respectively, Figures 6A and 6B). 
Similarly, twelve-month-old male FKBP52+/- mice fell from the rod before their FKBP52+/+ 
littermates in trial 5, 6, 7, 8 and 9 (p = 0.0305, p = 0.0297, p = 0.0192, p = 0.0151, p = 0.0154 
and p = 0.0157, respectively, Figures 6F). The performance index showed that twelve-month-
old female FKBP52+/- mice performed worse than ten-month-old female FKBP52+/- mice (p = 
0.0014), as did their male counterparts (p = 0.0557; Figures 6C and G). 
Considering a wider age range in experiment 2, experimentally naïve fifteen-month-old mice 
stayed on the rod for a shorter time than two-month-old mice (p = 0.043, Figures 7C and 7G). 
Within each age-group, female FKBP52+/- and FKBP52+/+ mice stayed on the accelerating 
rod for a similar length of time; except at two-months-of-age, where FKBP52+/- mice 
remained on it for longer than FKBP52+/+ mice in the very first trial (p = 0.0414, Figure 7A). 
A different picture emerged in male mice where two-month-old male FKBP52+/- mice 
performed overall worse than their FKBP52+/+ littermates which was significant in trial 5 and 
7 (p = 0.0139 and p = 0.285, respectively, Figure 7E). Conversely, twelve-month-old 
FKBP52+/- mice stayed on the rod for longer than FKBP52+/+ mice in trial 5 (p = 0.0424, 
Figure 7F). At eighteen-months-of-age FKBP52+/- mice fell off the rod before FKBP52+/+ 
mice in trial 9 (p = 0.0214; Figures 7H). 
In experiment 3, twelve-month-old female FKBP52-/- mice stayed on the accelerating rod for 
longer than FKBP52+/+ and FKBP52+/- mice (visual inspection). The latter two groups 
appeared to perform similarly in both sexes (Figures 6 D and H). 
 
Overall, knock-down of FKBP52 expression affected the mice’s motor coordination 
negatively by reducing the duration the mice stayed on the accelerating rotating rod. This has 
been seen in both sexes and age-groups investigated. The effect was unrelated to a change in 
motor activity as observed in the open field; and it was stronger when mice were repeatedly 
tested at ten- and twelve-months-of age.  
 
3.7 Acoustic startle response and prepulse inhibition 
In experiment 1, the latency to startle was statistically affected by genotype as function of age 
and sex (F(1, 42) = 6.47, p = 0.0147, Figure 8A). A genotype-effect was not observed in 
experimentally naïve mice ranging from two- to eighteen-months-of-age (experiment 2; 
Figure 8B) or in experiment 3 comprising twelve-month-old FKBP52+/+, FKBP52+/- and 
FKBP52-/- mice (Figure 8C). The magnitude of the startle response as well as prepulse 
inhibition was not altered by the mice’s genotype in experiments 1, 2, and 3; but decreased 
from two- to eighteen-months-of-age in experiment 2 (age: F(3,150) = 6.32, p = 0.0005; 
Supplementary Figures S6 and S7). 
In summary, the acoustic startle response and its inhibition were not affected by knocking 
down FKBP52 in mice. 
 
3.8 Contextual fear conditioning 
Immobility times and extinction index obtained from the three contextual fear conditioning 
experiments were not affected by the mice’s genotype (see Supplementary Figures S8, S9, 
S10 and S11; suggesting no role for FKBP52 in fear acquisition, memory and extinction.  
 
3.9 Elevated plus maze 
ANOVA results of experiment 2 indicated that genotype affected the time the mice spent on 
the open arm of the elevated plus maze in an age-dependent manner (F(3, 147) = 4.08, p = 
0.0081), but this was only significant at the eighteen-month-old group level where FKBP52+/+ 
males showed higher preference for open arms, compared to FKBP52+/-littermates (Figure 
9B). Further, within each age group, all mice spent a similar amount of time on the open arm 
in experiment 1 and 3 (Figures 9A and C, respectively). Thus, knocking down FKBP52 did 
not result in consistently altered emotionality-related behaviour on the elevated plus maze in 
mice. 
 
Taken all results of this study together, knocking down FKBP52 in mice worsened 
performance on an accelerating rotating rod but failed to alter the cognitive parameters tested. 
 
4 Discussion 
The present study aimed to assess the behavioural and cognitive phenotype of ageing 
FKBP52+/- mice; in light of raised FKBP52 levels in senescent C57Bl/6N brains [11] and the 
potential involvement of FKBP52 in the pathology of age-related diseases with dementia, 
such as AD [3, 12, 14, 15]. The main question in this regard was whether reduced levels of 
this protein alone – as found in post-mortem AD brains [15] – affected cognition and 
behaviour of genetically modified mice. Given FKBP52’s significance in the reproductive 
system [3, 39] male and female mice were tested at different age groups covering pre- and 
post-reproductive periods including senescence. 
Our main finding is that FKBP52 deficient mice were cognitively unimpaired and were 
statistically significantly different from their FKBP52+/+ littermates in only a few of the 19 
parameters that tested for body mass, species-specific behaviour, locomotor activity, motor 
coordination and, fear-, object-related and spatial memory as well as curiosity and 
emotionality. Most consistently, FKBP52+/- mice showed impairments in motor function as 
tested by an accelerating rotating rod. The behavioural phenotype of FKBP52 null mice was, 
however, very mild, and given the low number of surviving mice, this suggests that 
compensatory mechanisms may have taken place in this subset of mice. 
The finding of FKBP52+/- mice spending less time on the accelerod than their FKBP52+/+ 
littermates was consistent across the three experiments of the present study. This observation 
was least prominent in twelve-month-old mice of experiment 3 which might have been due to 
its reduced statistical power. Experiment 1 demonstrated that repeated testing after two 
months exacerbated the deficit seen in FKBP52+/- mice. Hence, FKBP52+/- mice’s untimely 
falls from the rod were likely due to a compromised ability to learn within a framework 
requiring motor coordination and balance [33].  
FKBP52+/- mice’s impairments in motor coordination were independent of their locomotor 
activity since FKBP52+/- and FKBP52+/+ mice covered a similar distance in the open field 
over thirty minutes, consistent with a previous report [7]. Whether FKBP52+/- mice showed 
decreased endurance [40] is unclear. However, they did not appear to display an altered 
motivation considering other tasks assessing exploratory drive, i.e. arm visits in the Y-maze 
or object exploration in the novel object tasks [23, 41] in which FKBP52+/- mice did not 
display a consistent distinct behaviour. Support for the observation of FKBP52 not being 
involved in processes controlling exploratory behaviour is further provided by a report of old 
C57Bl/6N mice who showed a physiological age-dependent increase of cerebral FKBP52 
levels but unaltered object exploration performance in a novel object recognition paradigm 
[11]. An intriguing observation of experiment 3 was that twelve-month-old female FKBP52-/- 
mice stayed on the accelerating rod for much longer than either FKBP52+/+ or FKBP52+/- 
mice. This could perhaps be explained by their behaviour in the open field and Y-maze which 
pointed at a rather active phenotype [24, 27]. 
To date, altered motor function has not been reported as a feature of the FKBP52+/- phenotype 
[7]. However, progressive deficits in motor coordination have been linked to 
neurodegeneration in a number of animals models [42-44], and FKBP52 was found to 
have a regenerative potential, promoting neuronal differentiation and neurite 
outgrowth in primary cell culture [45, 46], suggesting that downregulation of FKBP52 
levels may lead to neurodegenerative changes to the brain. In humans, FKBP52 has 
recently been investigated in diseases that present features of motor dysfunction: For 
example, low levels of FKBP52 have been measured in post-mortem brains obtained from 
patients diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17 
[15]. On the other hand, high levels of FKBP52 were linked to increased α-synuclein 
aggregation – a key feature of Parkinson’s disease pathology – in vitro [47]. These 
contradictory findings may therefore point towards a disease-dependent system in which 
FKBP52 is either ascribed protective or adverse properties. In both cases, FKBP52 has been 
suggested as a potential pharmaceutical target in the causative treatment of Alzheimer’s [3] 
and Parkinson’s disease [47, 48].  
FKBP52’s binding to glucocorticoid receptors is dependent on its exchange with FKBP51 
[6]. Both proteins have theoretically been linked to mood disorders [49, 50]. However, until 
now, pre-clinical studies have demonstrated a robust association of FKBP51 with stress 
response and depression-like behaviour [4, 49, 51-55], but to the author’s knowledge, no 
study has been published on FKBP52 and depression or another mood-disorder yet. However, 
FKBP52+/- mice appear to be more sensitive to stress, applied through chronic social defeat, 
than FKBP52+/+ mice in some behavioural paradigms tested like in a sociability test [7]. 
Although, a more robust behaviour was also observed in stressed FKBP52+/- mice in other 
tasks, such as the latency to first floating in a forced swim test [7]. Unstressed mice of both 
genotypes appear to behave alike in a number of paradigms measuring emotionality-related 
parameters, such as the time struggling and floating in the forced swim test or relative time 
spent in the centre zone of an open field [7]. Matching those observations is the result of the 
present study: FKBP52+/- and FKBP52+/+ mice spent a similar amount of time in the centre of 
an open field; suggesting reduced FKBP52+/- levels in the mouse brain [7] were not in 
themselves reflected in an anxiety-related profile. The present observation of FKBP52+/- and 
FKBP52+/+ mice spending a similar amount of time in the open arms of an elevated plus maze 
further supports this, is, however, in disagreement with a previous report [7]. One possible 
explanation is that mice in our study were subjected to elevated plus maze at the end of the 
behavioural battery, whereby repeated handling may have alleviated their anxiogenic-like 
behaviour. 
FKBP52+/- further appeared to perform similarly to age- and sex-matched FKBP52+/+ mice in 
terms of species-specific behaviour, i.e. food burrowing, and in terms of learning and 
memory in a spatial, object-oriented or fear context at all ages tested (from two- to eighteen-
months-of-age) which has not been investigated before. It has, however, been shown that 
increased FKBP52 levels in aged C57Bl/6N mice were not associated with deficits in an 
object recognition task [11]. Thus, together with our findings, this rules out a role of FKBP52 
in recognition memory. 
The observation of female mice being lighter than male mice is consistent with previous 
reports of C57Bl/6J and Sv129 x C57BL/6J control mice [56, 57]. A steady increase in body 
mass from two- to eighteen-months-of-age irrespective of sex, as found in experiment 2, has 
been reported for C57Bl/6J and Sv129 x C57BL/6J control mice in the past [56, 57]. The 
amount of food burrowed declined with age, as shown previously in C57Bl/6J mice ranging 
from two- to twelve- [20] and from four- to twenty-one-months-of-age [58]. Similarly, 
locomotor activity has been shown to decrease with advancing age [59] like in the present 
study. The magnitude of the acoustic startle response also decreased with mouse age which 
seems to be consistent with a published report [60]. In the contextual fear paradigm of 
experiment 2, two-month-old male and female mice became similarly more and more 
immobile with increasing number of electric shocks applied to their feet; as found previously 
[48, 61]. 
5 Conclusion – Outlook  
 
In the past, low levels of FKBP52 have been associated with high levels of tau in AD [15]. A 
causal relationship between FKBP52 and tau has also been demonstrated in vitro [14]. 
Furthermore, FKBP52 has been ascribed a modulatory role in Aβ-toxicity in a genetic 
construct of AD [12]. Whilst it has been shown that tau levels are predictive of cognitive 
decline in AD [13], it has not been tested whether FKBP52 in itself affects cognition or 
behaviour relevant to AD. The results of the present study, namely that FKBP52+/- mice 
appeared to be cognitively and behaviourally comparable to FKBP52+/+ mice over a wide 
range of ages and across sexes – with the exception of motor coordination –, now confirmed 
that reduced FKBP52 levels are not a risk factor to cognitive decline as seen in AD. This 
is in keeping with a previous report that found no relationship between object memory and 
cerebral FKBP52 levels [11]. Therefore, FKBP52 is more likely to play a modulatory role in 
the pathology of AD, but the motor coordination deficits associated with reduced 
FKBP52 levels suggest that this protein is neuroprotective in ageing.  
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Figures legends 
Figure 1. Order of behavioural and cognitive tests FKBP52+/+, FKBP52+/- mice and 
FKBP52-/- mice underwent over fifteen days in (1 A) experiment 1 and (1 B) experiments 2 
and 3. Experiment 1 was characterised by the re-use of FKBP52+/+, FKBP52+/- mice at 
twelve-months-of-age after initial testing at ten-months-of-age. Since contextual fear 
conditioning and elevated plus maze testing (indicated by *) are not repeatable [62], 
experiment 1 mice were subjected to these two tests at twelve-months-of-age only. 
Experiment 2 covered an age-range from two- to eighteen-months-of-age in experimentally 
naïve FKBP52+/+ and FKBP52+/- mice; whilst experiment 3 saw the addition of FKBP52-/- 
mice at twelve-months-of-age.  
Figure 2. Body mass measurements recorded for male and female FKBP52+/+, FKBP52+/- 
and FKBP52-/- mice at different ages in three separate experiments. Whilst female FKBP52+/- 
mice weighed more than FKBP52+/- mice in experiment 1 (2 A), this could not be confirmed 
by data obtained from experiment 2 (2 B) or 3 (2 C). KEY: F female, M male; ** p < 0.01 
(ANOVA/mixed model post-hoc planned comparison). 
Figure 3. Number of arms visited in a Y-maze by female and male FKBP52+/+, FKBP52+/- 
and FKBP52-/- mice at different ages in three separate experiments. Statistical analysis of 
experiment 2 flagged up a genotype-related difference in this parameter which was, however, 
only significant between fifteen-month-old female FKBP52+/- and FKBP52+/+ mice (3 B). 
KEY: F female, M male; ** p < 0.01 (ANOVA/mixed model post-hoc planned comparison). 
Figure 4. Total distance moved in the open field by male and female FKBP52+/+, 
FKBP52+/- and FKBP52-/- mice at different ages in three separate experiments. Whilst 
FKBP52+/- mice did not differ from FKBP52+/+ mice in terms of locomotor activity (4 A and 
4 B); experiment 3 (4 C) highlighted that female FKBP52-/- mice covered a greater distance 
than female FKBP52+/- and FKBP52+/+ mice – reaching locomotor activity levels of male 
FKBP52+/- and FKBP52-/- mice. The opposite was observed for male FKBP52-/- mice. KEY: 
F female, M male. 
Figure 5. Preference indices within the novel object discrimination paradigm: For male 
and female FKBP52+/+, FKBP52+/- and FKBP52-/- mice at different ages in three separate 
experiments. Repeatedly tested twelve-month-old female FKBP52+/+ mice spent more time 
exploring a novel object than their FKBP52+/- littermates (5 A). This observation was not 
robust when explored in naïvely tested mice of experiment 2 (5 B) and 3 (5 C). KEY: F 
female, M male; * p < 0.05 (ANOVA/mixed model post-hoc planned comparison), and # p < 
0.05 (one-sample t-test; comparison of means to 50 %). 
Figure 6. Accelerod performance in the longitudinal experiment 1 testing the latency to 
fall from an accelerating rotating rod of (6 A) ten- and (6 B) twelve-month-old females, as 
well as (6 E) ten- and (6 F) twelve-month-old male FKBP52+/+ and FKBP52+/- mice. Figures 
(6 C) and (6 G) illustrate the change in performance from ten- to twelve months in female 
and male mice, respectively. FKBP52+/- mice remained on the rods for shorter than 
FKBP52+/+ mice which was more obvious in repeatedly tested mice at twelve-months-of-age. 
(6 D, 6 H) Accelerod performance in experiment 3 of female (6 D) and male (6 H) 
FKBP52+/+, FKBP52+/- and FKBP52-/- mice; whereby latency to fall from the rod is shown. 
Experimentally naïve twelve-month-old FKBP52+/- and FKBP52+/+ mice performed similarly; 
but female FKBP52-/- mice remained on the rod for longer than female FKBP52+/- and 
FKBP52+/+ mice. This may be explained by their increased locomotor activity measured in 
the open field. KEY: * p < 0.05, ** p < 0.01 (ANCOVA/mixed model post-hoc planned 
comparison). 
Figure 7. Accelerod performance in the cross-sectional experiment 2 of two- (6 A, 6 E), 
twelve- (6 B, 6 F), fifteen- (6 C, 6 G) and eighteen-month-old (6 D, 6 H) female (6 A-D) and 
male (6 E-H) FKBP52+/+ and FKBP52+/- mice; whereby latency to fall from the rod is shown. 
Overall, experimentally naïve FKBP52+/- mice appeared to perform worse on the accelerating 
rotating rod than age- and sex-matched FKBP52+/+ mice; however, at age- and sex- level 
these differences seemed small and punctual. KEY: * p < 0.05 (ANCOVA/mixed model post-
hoc planned comparison). 
Figure 8. Latency of acoustic startle response of male and female FKBP52+/+, FKBP52+/- 
and FKBP52-/- mice at different ages in three separate experiments. Statistical analysis 
pointed towards an overall genotype-effect of the latency of an acoustic startle response in 
experiment 1 only (8 A). This trend did not reach significance at age- or sex-level. KEY: F 
female, M male. 
Figure 9. Preference for open arms of the elevated plus-maze by male and female 
FKBP52+/+, FKBP52+/- and FKBP52-/- mice at different ages in three separate experiments. 
The genotypes did not differ from each other in the time the mice spent on the open arm of an 
elevated plus maze; except between eighteen-month-old FKBP52+/- and FKBP52+/+ mice of 
experiment 2 (9 B). KEY: F female, M male; * p < 0.05 (ANOVA/mixed model post-hoc 
planned comparison). 
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Caption to figure 1: Number of mice used in experiments 1, 2 and 3.  
experiment age genotype 
 (months) FKBP52+/+ FKBP52+/- FKBP52-/- 
  female male female male female male* 
        
1 10 and 12 12 12 12 11 - - 
        
2 2 12 12 12 12 - - 
 12 12 12 12 12 - - 
 15 10 9 10 6 - - 
 18 9 10 8 9 - - 
        
3 12 11 10 5 5 6 5 
        
* some FKBP52-/- mice displayed intersex characteristics externally presented with under-
developed testicles upon dissection. Female FKBP52-/- mice appeared inconspicuous. 
 
  
Caption to table 2: ANOVA results of body mass, behavioural and cognitive tests that 
indicated a significant effect of FKBP52 knock-down in experiment 1 and 2. Summary of 
main findings in experiment 3. KEY: df degree(s) of freedom, R residuals, F F-value, p p-
value. 
 test parameter effect df R F p comment 
         
ex
p
er
im
en
t 
1
 
body mass body mass genotype 1 43 5.28 0.0265 female 
FKBP52+/- 
heavier than 
FKBP52+/+ 
novel object preference 
for novel 
object 
genotype 1 41 4.34 0.0435 12-month-old 
female 
FKBP52+/- 
explored novel 
object less 
than 
FKBP52+/+ 
accelerod performance 
index 
genotype x 
age 
1 33 4.25 0.0472 FKBP52+/-’s 
latency to fall 
decreased with 
age 
 latency to 
fall at 10 
months 
genotype x 
sex x trial 
8 272 2.02 0.0441 female 
FKBP52+/- fell 
off the rod 
before 
FKBP52+/+ 
 latency to 
fall at 12 
months 
genotype 1 33 5.29 0.0279 FKBP52+/- fell 
off the rod 
before 
FKBP52+/+ 
acoustic 
startle 
response 
startle 
latency 
genotype x 
age x sex 
1 42 6.47 0.0147 not significant 
at age level 
         
ex
p
er
im
en
t 
2
 
spontaneous 
alternation 
number of 
arms entered 
genotype x 
age 
3 151 2.99 0.033 15-month-old 
female 
FKBP52+/- 
visited less 
arms than 
FKBP52+/+  
accelerod latency to 
fall 
genotype x 
age x trial 
24 1200 2.26 0.0005 FKBP52+/- fell 
off the rod 
before 
FKBP52+/+ 
elevated 
plus-maze 
relative time 
spent in 
open arm 
genotype x 
age 
3 147 4.08 0.0081 18-month-old 
male 
FKBP52+/- less 
time in open 
arms than 
FKBP52+/+ 
         
ex
p
er
im
en
t 
3
 open field distance 
moved 
female FKBP52-/- moved more than FKBP52+/- and 
FKBP52+/+; male (inter-sex) FKBP52-/- moved less than 
male FKBP52+/- and FKBP52+/+ 
accelerod latency to 
fall 
female FKBP52-/- stayed on the rod for longer than 
FKBP52+/- and FKBP52+/+ 
   
    
 
 
Supplementary Material
1 Statistical results
All AN(C)OVA and mixed model results obtained from body mass, behavioural and
cognitive measurements that were recorded in experiment 1 and 2 are summarised in
Supplementary Tables 1 and 2, respectively. All results that demonstrate a main effect of
genotype or its interaction with mouse sex or age are discussed in the main article. All other
results are described in conjunction with the Supplementary Figures in the following.
2 Supplementary tables
Supplementary Table T1. AN(C)OVA results from body mass measurements and
behavioural and cognitive performances recorded in longitudinal experiment 1
comprising ten- and twelve-month-old FKBP52+/+ and FKBP52+/- mice. KEY: df degrees of
freedom; R residuals.
TEST PARAMETER effect df R F-value p-value
body mass mass genotype 1 43 5.28 0.0265
age 1 43 101.67 < 0.0010
sex 1 43 1.78 0.1891
genotype x sex 1 43 3.3 0.0761
genotype x age 1 43 1.89 0.1762
sex x age 1 43 0.05 0.8293
genotype x age x sex 1 43 0.17 0.68
food burrowing % fooddisplaced genotype 1 43 2.52 0.1198
age 1 42 3.21 0.0804
sex 1 43 0 0.989
genotype x sex 1 43 0.53 0.472
genotype x age 1 42 3.52 0.0678
sex x age 1 42 1.81 0.186
genotype x age x sex 1 42 0.12 0.7289
body weight 1 42 6.2 0.0168
spontaneous % alternation genotype 1 43 0.06 0.8087
alternation age 1 43 0.18 0.6728
sex 1 43 0.23 0.6344
genotype x sex 1 43 0.16 0.6925
genotype x age 1 43 1.1 0.3003
sex x age 1 43 3.03 0.0887
genotype x age x sex 1 43 0.14 0.709
number of arms genotype 1 43 0.75 0.3908
entered age 1 43 2.04 0.1608
sex 1 43 0.03 0.8537
genotype x sex 1 43 0 0.9989
genotype x age 1 43 0.04 0.8375
sex x age 1 43 13.92 0.0006
genotype x age x sex 1 43 0.2 0.6548
open field total distance genotype 1 43 0.11 0.7395
moved age 1 43 17.76 0.0001
sex 1 43 0.35 0.5546
genotype x sex 1 43 2.41 0.1279
genotype x age 1 43 0.18 0.6761
sex x age 1 43 0.85 0.3628
genotype x age x sex 1 43 0.33 0.5679
% distance
moved genotype 1 43 0.22 0.6377
in centre age 1 43 0.48 0.4899
sex 1 43 0 0.9948
genotype x sex 1 43 1.71 0.1978
genotype x age 1 43 0 0.9795
sex x age 1 43 0 0.9838
genotype x age x sex 1 43 0.48 0.4921
novel object
- habituation total exploration genotype 1 43 0 0.9721
time age 1 43 0.51 0.4827
sex 1 43 2.8 0.1018
genotype x sex 1 43 0.04 0.8494
genotype x age 1 43 0.47 0.5006
sex x age 1 43 2.07 0.1684
genotype x age x sex 1 43 0.95 0.3441
- location total exploration genotype 1 43 0.02 0.8796
time age 1 43 0.34 0.5667
sex 1 43 0.56 0.4596
genotype x sex 1 43 1.67 0.2032
genotype x age 1 43 0.1 0.758
sex x age 1 43 0.03 0.8581
genotype x age x sex 1 43 2.44 0.1393
preference index genotype 1 43 1.04 0.3131
age 1 43 3.28 0.0902
sex 1 43 0.02 0.8978
genotype x sex 1 43 0.88 0.3531
genotype x age 1 43 0.03 0.8613
sex x age 1 43 1.14 0.3031
genotype x age x sex 1 43 1.7 0.212
- discrimination total exploration genotype 1 43 0.19 0.6658
time age 1 43 2.07 0.1683
sex 1 43 4.64 0.0371
genotype x sex 1 43 0.55 0.4645
genotype x age 1 43 0.01 0.9069
sex x age 1 43 1.61 0.2218
genotype x age x sex 1 43 2.73 0.1168
preference index genotype 1 43 4.34 0.0435
age 1 43 0.55 0.5306
sex 1 43 0.4 0.4677
genotype x sex 1 43 0.97 0.3309
genotype x age 1 43 1.8 0.1975
sex x age 1 43 1.8 0.1974
genotype x age x sex 1 43 0.09 0.7665
accelerod latency to fall genotype 1 33 0.74 0.3947
(at 10 months) sex 1 33 0.46 0.5018
trial 8 272 38.6 < 0.0010
genotype x sex 1 33 0.18 0.671
genotype x trial 8 272 0.6 0.7747
sex x trial 8 272 1.81 0.0759
genotype x sex x
trial 8 272 2.02 0.0441
body weight 1 33 1.45 0.2379
accelerod latency to fall genotype 1 33 5.29 0.0279
(at 12 months) sex 1 33 8.26 0.007
trial 8 272 14.56 < 0.0010
genotype x sex 1 33 1.21 0.2792
genotype x trial 8 272 1.8 0.0769
sex x trial 8 272 1.72 0.0931
genotype x sex x trial 8 272 0.67 0.7214
body weight 1 33 2.76 0.106
accelerod performance genotype 1 34 0.57 0.4568
index age 1 33 10.8 0.0024
sex 1 34 1.57 0.2184
genotype x sex 1 34 2.94 0.0953
genotype x age 1 33 4.25 0.0472
sex x age 1 33 1.6 0.2142
body weight 1 33 0.59 0.4474
genotype x age x sex 1 33 0.08 0.7828
acoustic startle startle latency genotype 1 43 0.24 0.6289
response age 1 42 0.32 0.572
sex 1 43 0.07 0.7903
genotype x sex 1 43 0.51 0.4772
genotype x age 1 42 0.11 0.7457
sex x age 1 42 0.56 0.4566
genotype x age x sex 1 42 6.47 0.0147
body weight 1 42 0.41 0.5256
startle magnitude genotype 1 43 0.39 0.535
age 1 42 6.33 0.0158
sex 1 43 0.13 0.7166
genotype x sex 1 43 0.04 0.8434
genotype x age 1 42 0.14 0.7107
sex x age 1 42 2.15 0.1503
genotype x age x sex 1 42 0.06 0.8118
body weight 1 42 4.35 0.0432
% prepulse genotype 1 42 1.38 0.2475
inhibition sex 1 42 4.45 0.0409
(at 10 months) dB level 3 129 20.08 < 0.0010
genotype x sex 1 42 0.17 0.6845
genotype x dB level 3 129 0.22 0.885
sex x dB level 3 129 1.09 0.3557
genotype x sex x dB 3 129 1.26 0.2919
level
body weight 1 42 10.26 0.0026
% prepulse
inhibition genotype 1 42 0.06 0.8075
(at 12 months) sex 1 42 3.8 0.0578
dB level 3 129 8.71 < 0.0010
genotype x sex 1 42 2.91 0.0953
genotype x dB level 3 129 0.75 0.5225
sex x dB level 3 129 0.67 0.5707
genotype x sex x dB
level 3 129 0.24 0.8707
body weight 1 42 4.24 0.0458
contextual fear time immobile genotype 1 43 0.67 0.4174
(at 12 months) (fear memory sex 1 43 5.32 0.0259
acquisition) shock 9 387 66.06 < 0.0010
genotype x sex 1 43 0.11 0.7441
genotype x shock 9 387 1.74 0.0785
sex x shock 9 387 3.64 0.0002
genotype x sex x
shock 9 387 1.34 0.2165
time immobile genotype 1 43 0 0.9894
(fear memory sex 1 43 1.97 0.1672
retention) genotype x sex 1 43 0.73 0.3981
time immobile genotype 1 43 0.09 0.7625
(fear memory sex 1 43 1.3 0.2599
extinction) genotype x sex 1 43 0 0.9522
extinction index genotype 1 43 0.44 0.5109
sex 1 43 0.6 0.4439
genotype x sex 1 43 3.2 0.0809
elevated plus-maze % Time spent in genotype 1 40 0.72 0.4018
(at 12 months) open arms sex 1 40 0.35 0.5547
genotype x sex 1 40 0.16 0.6955
Supplementary Table T2. AN(C)OVA results from body mass measurements and
behavioural and cognitive performances recorded in experiment 2 comprising
experimentally naïve FKBP52+/+ and FKBP52+/- mice at two-, twelve-, fifteen- and eighteen-
months-of-age. KEY: df degrees of freedom; R residuals.
TEST PARAMETER Effect df R F-value p-value
body mass mass genotype 1 151 0.37 0.5435
age 3 151 136.05 <0.0001
sex 1 151 29.11 <0.0001
genotype x age 3 151 1.19 0.3152
age x sex 3 151 1.96 0.1227
genotype x sex 1 151 0.04 0.8496
genotype x age x sex 3 151 0.49 0.6931
food burrowing % food genotype 1 150 0.51 0.4753
burrowed age 3 150 2.53 0.0594
sex 1 150 0.97 0.3258
genotype x age 3 150 2.01 0.1143
age x sex 3 150 2.43 0.0671
genotype x sex 1 150 2.03 0.1564
genotype x age x sex 3 150 1.01 0.3898
body weight 1 150 5.22 0.0238
spontaneous % alternation genotype 1 151 1.02 0.3133
alternation age 3 151 0.74 0.5322
sex 1 151 1.62 0.2054
genotype x age 3 151 0.24 0.8664
age x sex 3 151 0.82 0.4846
genotype x sex 1 151 1.01 0.3154
genotype x age x sex 3 151 1.41 0.2414
number of genotype 1 151 2.7 0.1026
arms entered age 3 151 15.7 <0.0001
sex 1 151 4.96 0.0275
genotype x age 3 151 2.99 0.033
age x sex 3 151 0.4 0.7563
genotype x sex 1 151 0.01 0.915
genotype x age x sex 3 151 0.72 0.5408
open field total distance genotype 1 151 1.81 0.18
moved age 3 151 13.78 <0.0001
sex 1 151 5.86 0.0167
genotype x age 3 151 1.44 0.2332
age x sex 3 151 4.47 0.0049
genotype x sex 1 151 0.19 0.3741
genotype x age x sex 3 151 0.11 0.9557
% distance genotype 1 151 0.96 0.3285
moved in age 3 151 9.46 <0.0001
centre sex 1 151 14.47 0.0002
genotype x age 3 151 0.86 0.4616
age x sex 3 151 2.14 0.0976
genotype x sex 1 151 1.97 0.1628
genotype x age x sex 3 151 0.38 0.7642
novel object
- habituation total genotype 1 140 0.59 0.4449
exploration age 3 140 0.46 0.7104
time sex 1 140 3.55 0.0617
genotype x age 3 140 0.07 0.9751
age x sex 3 140 0.19 0.9021
genotype x sex 1 140 0 0.9819
genotype x age x sex 3 140 1 0.3934
- location total genotype 1 142 1 0.3194
exploration age 3 142 0.08 0.9695
time sex 1 142 0.04 0.8466
genotype x age 3 142 1.33 0.2674
age x sex 3 142 0.86 0.4645
genotype x sex 1 142 3.61 0.0596
genotype x age x sex 3 142 0.14 0.9372
preference genotype 1 142 0.01 0.9428
index age 3 142 1.02 0.3858
sex 1 142 0.48 0.4885
genotype x age 3 142 2.03 0.1126
age x sex 3 142 0.17 0.9175
genotype x sex 1 142 0 0.984
genotype x age x sex 3 142 2.2 0.0907
- discrimination total genotype 1 132 1.57 0.2123
exploration age 3 132 0.26 0.8570
time sex 1 132 0.12 0.7322
genotype x age 3 132 0.52 0.6717
age x sex 3 132 2.84 0.0406
genotype x sex 1 132 0 0.9614
genotype x age x sex 3 132 0.42 0.7418
preference genotype 1 132 0.08 0.7785
index age 3 132 1.42 0.2412
sex 1 132 1.15 0.285
genotype x age 3 132 1.1 0.3537
age x sex 3 132 0.29 0.8327
genotype x sex 1 132 0 0.9703
genotype x age x sex 3 132 1.33 0.2662
accelerod latency to fall genotype 1 149 2.72 0.1009
age 3 149 2.98 0.0334
sex 1 149 1.76 0.1868
trial 8 1200 69.68 <0.0010
genotype x age 3 149 0.71 0.5495
age x sex 3 149 2.09 0.1045
age x trial 24 1200 5.22 <0.0010
genotype x sex 1 149 0.69 0.4092
genotype x trial 8 1200 1.81 0.0713
sex x trial 8 1200 2.42 0.0137
genotype x age x sex 3 149 0.81 0.491
genotype x age x
trial 24 1200 2.26 0.0005
age x sex x trial 24 1200 1.82 0.0089
genotype x sex x trial 8 1200 0.56 0.8077
genotype x age x sex
x trial 24 1200 1.16 0.2656
body weight 1 149 153.07 <0.0010
acoustic startle startle latency genotype 1 150 0.01 0.9317
response age 3 150 2.2 0.0899
sex 1 150 0.46 0.5002
genotype x age 3 150 0.08 0.9692
age x sex 3 150 0.84 0.4721
genotype x sex 1 150 0.1 0.7533
genotype x age x sex 3 150 0.72 0.5396
body weight 1 150 4.33 0.0391
startle genotype 1 150 0.93 0.3371
magnitude age 3 150 6.32 0.0005
sex 1 150 0.16 0.6933
genotype x age 3 150 0.24 0.8714
age x sex 3 150 0.21 0.8897
genotype x sex 1 150 0.04 0.8501
genotype x age x sex 3 150 0.36 0.7832
body weight 1 150 8 0.0053
% prepulse genotype 1 150 0.35 0.5567
inhibition age 3 150 6.39 0.0004
sex 1 150 0 0.9463
dB level 3 453 177.37 <0.0010
age x genotype 3 150 0.51 0.6787
age x sex 3 150 0.64 0.5917
age x dB level 9 453 4.41 <0.0010
genotype x sex 1 150 0.01 0.9214
genotype x dB level 3 453 0.82 0.4813
sex x dB level 3 453 0.64 0.5926
genotype x age x sex 3 150 2 0.1163
age x genotype x dB
level 9 453 1.44 0.1689
age x sex x dB level 9 453 1.12 0.3485
genotype x sex x dB
level 3 453 0.29 0.8304
age x genotype x sex 9 453 0.39 0.9416
x dB level
body weight 1 150 0.76 0.3833
contextual fear time immobile genotype 1 149 0.91 0.3422
conditioning (fear memory age 3 149 6.06 0.0006
acquisition) sex 1 149 6.7 0.0106
shock 9 1341 209.13 <0.0010
genotype x age 3 149 1.29 0.2812
age x sex 3 149 2.12 0.0997
age x shock 27 1341 2.33 0.0001
genotype x sex 1 149 0.64 0.4253
genotype x shock 9 1341 0.93 0.4934
sex x shock 9 1341 2.93 0.0019
genotype x age x sex 3 149 0.81 0.4898
genotype x age x
shock 27 1341 1.15 0.2702
age x sex x shock 27 1341 1.83 0.0058
genotype x sex x
shock 9 1341 0.73 0.6794
genotype x age x sex
x shock 27 1341 0.6 0.9464
time immobile genotype 1 148 0 0.9639
(fear memory age 3 148 1.59 0.1931
retention) sex 1 148 11.84 0.0008
genotype x age 3 148 1.49 0.219
age x sex 3 148 5.72 0.001
genotype x sex 1 148 0.33 0.5662
genotype x age x sex 3 148 0.59 0.625
time immobile genotype 1 148 1.02 0.3134
(fear Memory age 3 148 3.92 0.01
extinction) sex 1 148 21.3 < 0.0001
genotype x age 3 148 0.79 0.5037
age x sex 3 148 7.65 < 0.0001
genotype x sex 1 148 1.36 0.2447
genotype x age x sex 3 148 0.99 0.3977
extinction
index genotype 1 148 1.54 0.2166
age 3 148 0.62 0.6057
sex 1 148 1 0.3194
genotype x age 3 148 1.64 0.1835
age x sex 3 148 0.68 0.5652
genotype x sex 1 148 0.46 0.4979
genotype x age x sex 3 148 0.28 0.8426
elevated plus-maze % time spent in genotype 1 147 0.28 0.5986
open arms age 3 147 7.89 < 0.0001
sex 1 147 5.61 0.0192
genotype x age 3 147 4.08 0.0081
age x sex 3 147 1.37 0.2546
genotype x sex 1 147 0.69 0.4084
genotype x age x sex 3 147 0.23 0.8788
3 Supplementary figures: age- and sex-related results; irrespective of the FKBP52
genotype
3.1 Food burrowing
Supplementary Figure S1. Percentage of food displaced by male and female FKBP52+/+,
FKBP52+/- and FKBP52-/- mice at different ages in three separate experiments. Irrespective of
sex and genotype, mice tended to displace less food from a jar with increasing age – from
two- to eighteen-months-of-age – in experiment 2 (age: F(3, 150) = 2.53, p = 0.0594; S1 B).
Food burrowing behaviour was unaltered by any of the experimental conditions, i.e. age, sex
or genotype, in the other two experiments (S1 A, C).
. KEY: M male, F female.
3.2 Spontaneous alternation – alternation rate
Supplementary Figure S2. Comparable alternation rates of male and female FKBP52+/+,
FKBP52+/- and FKBP52-/- mice in a Y-maze, at different ages in three separate experiments.
Most mouse groups alternated above the 50%-chance level, except ten-month-old male mice
in experiment 1 (S2 A), fifteen-month-old male mice in experiment 2 (S2 B) and twelve-
month-old female mice in experiment 3 (S2 C). No group alternated at less than 50%. KEY:
M male, F female; # p < 0.05, ## p < 0.01, ### p < 0.001 (one-sample t-test, comparison of
means to 50%).
3.3 Open field – relative distance in the centre
Supplementary Figure S3. The relative distance that male and female FKBP52+/+ and
FKBP52+/- mice covered in the centre of the open field arena declined from two- to eighteen-
months-of-age (age: F(3, 151) = 9.46, p < 0.0001) and varied with sex (sex: F(1, 151) = 14.47, p =
0.0002) in experiment 2 (S3 B). This variable was unaffected by the experimental conditions
in experiment 1 (S3 B). In experiment 3, male FKBP52+/- mice appeared to cover a greater,
whereas male FKBP52-/- mice seemed to cover a shorter distance in the centre of the open
field than male FKBP52+/+ mice (S3 C). This observation was not supported by the statistics
of data collected from experiment 1 or 2.
KEY: M male, F female.
3.4 Novel object habituation, location and discrimination
Supplementary Figure S4. Total exploration times of two objects did not differ between
genotypes across all three novel object trials when male and female FKBP52+/+, FKBP52+/-
and FKBP52-/- mice were tested at different ages in three separate experiments. The time the
mice spent exploring both objects within the habituation and location trials was not affected
by the experimental conditions in experiment 1 and 2 (S4 A, 4 B, 4 D and 4 E). The total
exploration time of both objects in the discrimination trial depended on sex alone in
experiment 1 (sex: F(1, 43) = 4.64, p = 0.0371; S4 C) and on sex in an age-dependent manner
in experiment 2 (sex x age: F(3, 132) = 2.84, p = 0.0406; S4 F); but sex differences did not
follow a coherent pattern. KEY: M male, F female.
Supplementary Figure S5. Whether mice preferred to explore an object at a new or familiar
location was unaltered by genotype, sex or age in experiment 1, 2 and 3 (S5 A, B and C,
respectively); covering FKBP52+/+, FKBP52+/- and FKBP52-/- mice from two- to eighteen-
months-of-age (S5 B) and including effects of repeated testing (S5 A). The lack of genotype-
related deficits may have arisen from poor FKBP52+/+ performance which can currently not
be explained as the testes were performed according to a previously validated protocol
(Scullion et al., 2009).KEY: M male, F female; # p < 0.05 (one-sample t-test, comparison of
means to 50 %).

3.5 Acoustic startle magnitude
Supplementary Figure S6. Startle magnitude values recorded during the prepulse inhibition
protocol in male and female FKBP52+/+, FKBP52+/- and FKBP52-/- mice at different ages in
three separate experiments. Startle magnitude decreased with age irrespective of genotype or
sex in experiment 1 (age: F(1, 42) = 6.33, p = 0.0158; S6 A) and 2 (age: F(3, 150) = 6.39, p =
0.0004; S6 B). KEY: M male, F female.
3.6 Prepulse inhibition
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Supplementary Figure S7. dB-level and age-dependent percentage prepulse inhibition in
response to prepulse levels of 68, 72, 80 and 90 decibels (dB) by male and female
FKBP52+/+, FKBP52+/- and FKBP52-/- mice at different ages in experiment 1 (S7A and D),
experiment 2 (S7B and E) and experiment 3 (S7 C and F). The inhibition of the acoustic
startle response increased with the dB levels applied during the prepulse in experiment 1 at
ten- (dB level: F(3, 129) = 20.08, p < 0.0010) and twelve-months-of-age (dB level: F(3, 129) =
8.71, p < 0.0010; S7 A); as in experiment 2 as function of age; whereby inhibition was
reduced in eighteen-month-old mice (dB level x age: F(9, 453) = 4.41, p < 0.0010; S7 B).
3.7 Contextual fear
acquisition,
retention and
extinction
Supplementary Figure S8. Immobility in response to 0.4 mA foot shocks in the cross-
sectional experiment 2 of two- (S8 A and E), twelve- (S8 B and F), fifteen- (S8 C and G)
and eighteen-month-old (S8 D and H) male and female FKBP52+/+ and FKBP52+/- mice.
Both genotypes became increasingly immobile with repeated shock exposure; indicating
robust acquisition of contextual fear. The increasing immobility was affected by sex and age
(sex x age x shock: F(27, 1341) = 1.83, p = 0.0058).
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Supplementary Figure S9. Immobility in response to 0.4 mA foot shocks in twelve-month-
old mice in experiment 1 (S9 A and C) and experiment 3 (S9 B and D)
All experimental groups became increasingly immobile with repeated shock exposure,
indicating successful acquisition of contextual fear. The increasing immobility was affected
by sex in experiment 1 (sex x shock: F(9, 387) = 3.64, p = 0.0002; S9 A and C).
Supplementary Figure S10. Levels of immobility in the retention (S10 A and D) and
extinction (S10 B and E) trials of the experiment 2, following the contextual fear acquisition
trial, in male and female FKBP52+/+ and FKBP52+/- mice of different ages. Immobility in the
contextual fear retention and extinction trials was altered by sex in an age-dependent manner
in experiment 2 (sex x age: F(3, 148) = 5.72, p = 0.0010 and sex x age: F(3, 148) = 7.65, p <
0.0001, respectively); which was due to twelve-month-old males that remained more
immobile than two- (p = 0.0131 and p = 0.0016, respectively) and eighteen-month-old (p =
0.0235 and p = 0.007, respectively) males; and which was due to females being less
immobile than males in the retention and extinction trial (p = 0.001 and p < 0.001,
respectively).
The extent of contextual fear memory extinction was unaffected by the experimental
conditions and no genotype-group showed successful extinction of contextual fear (indicated
by negative index values) consistently. KEY: # p < 0.05 (one-sample t-test, comparison of
means to 0).
Supplementary Figure S11. Comparable levels of immobility in retention (S11 A and D)
and extinction (S11 B and E) trials, following the contextual fear acquisition trial, in twelve-
month-old female and male FKBP52+/+, FKBP52+/- and FKBP52-/- mice from experiment 1
(S11 A, B and C) and experiment 3 (S11 D, E and F). Sex-related trends observed in
experiment 2 were not apparent in experiment 1 or 3. All groups of experiment 1 (S11 C) and
3 (S11 F) were unsuccessful in extinguishing contextual fear memory.
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